Articles tagged with Migraines
Scientists discovered a correlation between adiponectin, a protein hormone from fat tissue, and migraine pain relief. The study found that increased levels of low molecular weight adiponectin were associated with reduced pain severity, while high molecular weight adiponectin was linked to increased pain.
A new study published in Neurology suggests that wearing a nerve stimulator for 20 minutes a day can reduce the frequency of migraine attacks. The device delivers electrical stimulation to the supraorbital nerve, resulting in fewer days with migraine and a significant reduction in attack frequency compared to sham treatment.
A study published in Cephalalgia found a significant correlation between lightning strikes and an increased risk of headache and migraine in chronic sufferers. The research suggests that electromagnetic waves emitted by lightning may trigger headaches, while also producing air pollutants that could lead to migraines.
A recent study found that only 22% of participants who reported certain triggers developed a migraine attack after exposure. The research suggests that people may no longer need to avoid suspected triggers if they don't experience a headache episode within three months.
Two studies found that migraine with aura is a strong contributor to cardiovascular events like heart attack and stroke. Women with this condition are more likely to experience blood clot complications, especially those on newer contraceptives.
A recent study found that individuals with a strong family history of seizure disorders are more likely to experience migraines with aura. The research, published in Epilepsia, analyzed data from over 730 participants with epilepsy and demonstrated a significant genetic link between the two conditions.
A nine-year follow-up study found that women with migraines did not exhibit declining cognitive abilities, unlike previous research suggesting a link between migraine and impaired cognition. Brain changes associated with bright spots on MRI scans were present in both men and women with migraines.
A study of 5,671 Brazilian children aged 5-12 found that those with migraines had lower school performance compared to those without headaches. Children with chronic or severe migraines were more likely to experience poor performance.
A large-scale study found that children with migraine headaches are more likely to experience social and attention issues, as well as anxiety and depression. The study, published in the journal Cephalalgia, suggests that headache frequency is a key factor in these behavioral difficulties.
A recent clinical trial published in Neurological Sciences demonstrates the efficacy of Sea-Band wristbands in reducing migraine-related nausea. The study showed significant improvement in nausea scores and a high percentage of responders to treatment, supporting the use of Sea-Band as a drug-free remedy for this condition.
The American Headache Society is focusing on traumatic brain injury in its scientific conference, with experts discussing earlier detection, prompt treatment, and prevention. The conference aims to raise awareness of the issue and reduce long-term consequences for affected individuals.
Scientists have identified four new genes that predispose people to the most common type of migraine, without aura. The study provides further evidence for the role of molecular signaling in migraine and opens new avenues for research into its causes.
A study by Griffith University has identified a new region on the X chromosome linked to migraine in females. The research suggests multiple genes may be involved, including one related to iron regulation in the brain.
A review of previous studies found that Botox injections are associated with a small to modest benefit for patients with chronic migraine and chronic daily headaches, but not for episodic migraines or tension-type headaches. The treatment was linked to improved frequency of chronic conditions, such as headache reduction from 19.5 to 17.2.
The American Academy of Neurology issues new guidelines for preventing migraine, recommending several treatments including prescription drugs and over-the-counter options. These guidelines aim to address the underrecognition and undertreatment of migraine, with potential benefits in reducing attack frequency and severity.
Researchers link brain freeze to other headache types by studying blood flow in the brain. The study found that an abrupt increase in blood flow in the anterior cerebral artery triggers brain freeze and disappears when it constricts. This finding could lead to new treatments for various headache types.
A large study found that women with a history of migraine are 40% more likely to develop depression than those without. Researchers hope their findings will encourage doctors to discuss depression prevention with migraine patients.
A recent study suggests that mothers who experience migraines may be more likely to have infants with colic. The research, presented at the American Academy of Neurology's annual meeting, found that babies whose mothers had a history of migraine were two-and-a-half times more likely to have colic than those without.
A new study by neurologists at UCSF reveals that mothers who suffer from migraine headaches are more than twice as likely to have babies with colic. The research suggests a possible link between colic and childhood periodic syndromes, which may be precursors to migraine headaches later in life.
A study found that painACTION.com increased participants' confidence in preventing headaches and managing pain, leading to more daily activities and reduced depression, anxiety, and stress. The online intervention was effective as an adjunct to comprehensive medical care for chronic migraine management.
The new guidelines provide a contemporary, evidence-based approach for investigators conducting randomised, controlled migraine clinical trials. Key findings include the importance of patient selection, trial design, and evaluation of results in both acute and preventive settings.
Two randomized controlled trials found acupuncture to be equally effective as sham acupuncture in treating migraines. About half of patients showed improvement after 16 weeks. The clinical effect of acupuncture is considered minor and may be due to the placebo effect.
Research has found an association between marijuana use in young males and the development of cyclic vomiting syndrome (CVS), which shares clinical features with functional vomiting. CVS is more common among young males using marijuana, highlighting the need for further research into treatment options for this condition.
A randomized controlled study of 91 migraine patients found that exercise was as effective as topiramate in preventing migraines. The study revealed no difference in prevention effectiveness between the three treatments: exercise, relaxation exercises, and topiramate.
The five-year study aims to determine the medication of choice for preventing migraines in children and teens, addressing a significant gap in evidence-based research. The trial will compare amitriptyline and topiramate, investigating their efficacy and safety profiles in this age group.
Researchers developed a mouse model of Familial Hemiplegic Migraine type 2, showing increased susceptibility to cortical spreading depression. The study suggests that episodic disruptions in the excitation-inhibition balance may underlie migraine vulnerability.
According to a survey of 200 migraine specialists attending the American Headache Society meeting, increasing public funds for research is considered most promising. The majority believe new therapies will evolve from more investment in the field, while others see public awareness and education as crucial.
Researchers gather to share new scientific data on migraine disease, exploring its unique role of the thalamus, recent gene identification, and childhood abuse correlations. Migraine specialists welcome a new era of discovery and advancement in understanding and treating this disabling disease.
A notable prevalence of childhood abuse in migraine patients has been observed, with experts suggesting that early abuse may create permanent changes in the neurobiological system. Researchers are exploring the idea that treatment with serotonin-specific reuptake inhibitors may reverse some of these effects and decrease migraine pain.
Researchers found that migraine sufferers often experience fatigue, anxiety, mood changes, and yawning before an attack. Early intervention using triptans during the premonitory phase may help prevent or reduce the severity of attacks.
Research suggests the thalamus acts as a center for transmitting migraine pain, regulating its intensity and sensitivity to environmental stimuli. This new understanding may lead to future treatments targeting the thalamus.
A gene discovery for migraine may lead to the development of a preventive pill that blocks the brain's pain channel. The discovery is significant as it opens understanding of the pain pathways that trigger migraine pain, sparking excitement among researchers and the pharmaceutical industry.
Researchers used fMRI to identify how precision-tinted lenses work, finding that they normalize brain activity in patients with migraine headaches. The study showed a 70% improvement in symptoms compared to control lenses, suggesting a potential biomarker for identifying patients who may benefit from tinted lenses.
A new study published in Cephalalgia suggests that precision ophthalmic tints can suppress cortical activation in the brain, reducing migraine symptoms. The lenses significantly reduced discomfort when viewing stressful patterns, with a 70% reduction in distress.
Researchers at the University of Granada have identified specific trigger points in the head that contribute to migraine frequency and severity. Injecting botulinum toxin (botox) into these points reduces migraine crises by 50% or more in 18% of patients, with mild side effects.
Researchers found a connection between migraines with aura and patent foramen ovale in children, a common heart defect affecting 25% of the US population. The study suggests closure of PFO may help treat certain types of migraines, offering new hope for treatment.
Researchers found that headache frequency and severity decreased substantially after bariatric surgery, with nearly half of patients experiencing at least a 50% reduction in migraine frequency. Weight loss also led to significant improvements in disability related to migraines.
A study published in Plastic and Reconstructive Surgery found that nearly 90% of patients experienced at least partial relief from migraine headaches after five years. The surgery targets 'trigger sites' in the muscles or nerves producing pain, with significant improvements in quality of life.
Researchers found that women with migraine with aura are twice as likely to have no significant disability from stroke. This association may be due to smaller vessel mechanisms leading to mild strokes. The study's results offer reassuring news for migraine sufferers, suggesting a lower risk of severe outcomes.
Researchers found a link between low blood pressure at night and an increased risk of glaucoma in patients with migraine. Mobile devices like iPhones can also be used to evaluate ophthalmic images with high consistency, revolutionizing digital eye care.
A new Ohio University-led study suggests that combining preventive medication and behavioral changes offers significant relief from frequent, disabling migraines. The research found that the combination of these interventions resulted in a 77% reduction in migraine frequency, days with migraine, and improved quality of life.
A recent study by Université de Montréal researchers has identified the KCNK18 gene as a key player in common migraines. The mutation disrupts TRESK protein function, altering electrical activity in nerve cells and increasing migraine risk. This finding may lead to new treatment options for people suffering from recurrent headaches.
Researchers found that high-dose intravenous aspirin significantly reduced pain in patients with severe withdrawal headaches caused by medication overuse. The study showed that 25% of participants experienced a significant reduction in pain, while 40% reported a modest pain reduction.
A new study found that intravenous aspirin was associated with a 25% reduction in pain scores and moderate effectiveness in treating severe headaches. The treatment had six percent side effects, mostly nausea and vomiting.
A new study by Elizabeth Seng and Dr. Kenneth Holroyd found that psychological treatments significantly increase confidence in self-management abilities among severe migraine sufferers. Behavioral management programs alongside drug therapy led to increased confidence, especially among those with low control over their condition.
Researchers have discovered a genetic risk factor associated with common types of migraine, revealing a potential explanation for the link. A DNA variant on Chromosome 8 regulates glutamate levels in nerve cells, which may play a key role in migraine attacks.
A recent study has found that teenagers who are overweight, smoke, or get little exercise are more likely to experience frequent headaches. The research suggests that lifestyle factors such as regular physical activity, healthy food choices, and quitting smoking may be key to preventing headaches in teens.
A study of over 1,300 migraine patients found a link between childhood abuse and an increased risk of stroke, transient ischemic attack, and myocardial infarction. The research suggests that early adverse experiences may influence cardiovascular health in adulthood.
Research reveals increased network activity and altered functional connectivity in multiple networks, reflecting the migrainous phenotype. This suggests that migraine is a disorder of the brain, with abnormalities present even outside of attacks.
Research by Paul L. Dunham and his team at Missouri State University found that REM sleep deprivation increases expression of proteins p38, PKA, and P2X3, known for initiating and sustaining chronic pain in migraines.
A study of 17,337 adult members found a graded relationship between the number of adverse childhood experiences and the likelihood of experiencing frequent headaches. The researchers suggest that ACEs may contribute to the development and frequency of severe headaches later in life.
Researchers found chronic migraine sufferers experience higher levels of stigma, negatively impacting quality of life. The study, conducted by Dr. Jung E. Park and her team, used the Stigma Scale for Chronic Illness to assess stigma in outpatients with chronic and episodic migraines.
A study by the American Headache Society found that soldiers with post-traumatic headache and migraine reported improved sleep quality after three months of treatment. The research aimed to determine if effective headache treatment could also improve sleep quality among patients with these conditions.
Telcagepant, a CGRP receptor blocker, provides similar pain relief as triptans but with fewer cardiovascular risks. Topiramate may also prevent migraine attacks in chronic sufferers.
A single dose of aspirin (900-1000mg) significantly reduces migraine headache pain in over half of people, with added metoclopramide improving nausea and vomiting symptoms. Aspirin plus metoclopramide is a reasonable option for acute migraine attacks, but may not be effective enough for some.
A recent Harvard Medical School study found that uninsured individuals are twice as likely to receive substandard treatment for migraines compared to their privately insured counterparts. This disparity affects approximately 5.5 million people in the US who lack health insurance, leading to needless suffering and economic burden.
A study found that people with no health insurance are twice as likely to receive inadequate treatment for migraines compared to those with private insurance. Migraine patients on Medicaid are 1.5 times more likely to receive substandard care.
A new study suggests that people with migraines may struggle to filter out visual noise, even when they don't have a headache. Migraineurs performed significantly worse in identifying visual targets than those without migraines when visual distractions were added.
The Phase II clinical study investigated the efficacy and tolerability of OptiNose's novel, intranasal sumatriptan product for treating migraine. The results showed high efficacy, with pain-free rates at two hours being 54% for the 10mg dose and 57% for the 20mg dose.
A new hand-held device delivering magnetic pulses to the back of the head effectively treats migraine with aura in some patients, reducing pain and associated symptoms. The treatment is well-tolerated and non-inferior to sham stimulation for symptom improvement, making it a promising acute treatment option.